James Carmichael

1.5k total citations
11 papers, 325 citations indexed

About

James Carmichael is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James Carmichael has authored 11 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James Carmichael's work include Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Cardiac pacing and defibrillation studies (2 papers). James Carmichael is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Cardiac pacing and defibrillation studies (2 papers). James Carmichael collaborates with scholars based in United States, United Kingdom and Canada. James Carmichael's co-authors include Brian E. Cathers, Chin-Chun Lu, Philip P. Chamberlain, Gang Lu, Mary E. Matyskiela, Peter Schäfer, Weihong Zhang, Godrej Khambatta, Yoshitaka Satoh and Mariko Riley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medicinal Chemistry.

In The Last Decade

James Carmichael

10 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Carmichael United States 5 273 139 94 18 14 11 325
Svetlana Trestman Israel 9 115 0.4× 98 0.7× 98 1.0× 44 2.4× 12 0.9× 29 250
Eva H. N. Olsen United States 11 93 0.3× 150 1.1× 24 0.3× 13 0.7× 10 0.7× 15 281
Karen Norek United States 9 294 1.1× 133 1.0× 70 0.7× 21 1.2× 9 0.6× 15 365
Emanuela Ferrari Italy 9 228 0.8× 51 0.4× 57 0.6× 52 2.9× 3 0.2× 13 298
Margaretha S. Carlsson Sweden 5 180 0.7× 277 2.0× 176 1.9× 22 1.2× 3 0.2× 6 361
Afaf E.G. Osman United States 7 93 0.3× 121 0.9× 27 0.3× 15 0.8× 4 0.3× 20 201
Liangang Liu United States 11 178 0.7× 165 1.2× 108 1.1× 47 2.6× 3 0.2× 33 339
Katarzyna Anna Baranowska Norway 6 120 0.4× 75 0.5× 39 0.4× 19 1.1× 11 0.8× 11 176
Russell Mapes United States 8 308 1.1× 275 2.0× 158 1.7× 6 0.3× 2 0.1× 11 389
María Larrosa-García Spain 3 135 0.5× 192 1.4× 29 0.3× 10 0.6× 5 0.4× 12 290

Countries citing papers authored by James Carmichael

Since Specialization
Citations

This map shows the geographic impact of James Carmichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Carmichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Carmichael more than expected).

Fields of papers citing papers by James Carmichael

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Carmichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Carmichael. The network helps show where James Carmichael may publish in the future.

Co-authorship network of co-authors of James Carmichael

This figure shows the co-authorship network connecting the top 25 collaborators of James Carmichael. A scholar is included among the top collaborators of James Carmichael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Carmichael. James Carmichael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Moison, Céline, Julie Schmitt, Simon Girard, et al.. (2024). SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia. Science Advances. 10(12). eadl4018–eadl4018. 18 indexed citations
3.
Wong, Lilly, Rama Krishna Narla, Jim Leisten, et al.. (2019). CC-92480, a Novel Cereblon E3 Ligase Modulator, Is Synergistic with Dexamethasone, Bortezomib, and Daratumumab in Multiple Myeloma. Blood. 134(Supplement_1). 1815–1815. 12 indexed citations
4.
Patel, Mehul, James Carmichael, Heiko Schneider, et al.. (2018). 23 Long term lead survival in adult congenital heart disease patients: a retrospective analysis using clinical correspondence data mining. A22–A23. 1 indexed citations
5.
Lu, Gang, Mary E. Matyskiela, Xinde Zheng, et al.. (2018). UBE2G1 governs the destruction of cereblon neomorphic substrates. eLife. 7. 56 indexed citations
6.
Matyskiela, Mary E., Weihong Zhang, Hon‐Wah Man, et al.. (2017). A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos. Journal of Medicinal Chemistry. 61(2). 535–542. 203 indexed citations
7.
Mita, Monica, Edward M. Wolin, Tim Meyer, et al.. (2013). Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in nonpancreatic neuroendocrine tumors (NET).. Journal of Clinical Oncology. 31(15_suppl). e15004–e15004. 3 indexed citations
8.
Hoover, Craig A., James Carmichael, Paul E. Nolan, & Gregory M. Marcus. (1996). Cardiac Arrest Associated with Combination Cisapride and Itraconazole Therapy. Journal of Cardiovascular Pharmacology and Therapeutics. 1(3). 255–258. 22 indexed citations
9.
Carmichael, James, et al.. (1995). HIV/AIDS primary care handbook. 2 indexed citations
10.
Carmichael, James. (1983). The effect of cranklength on oxygen consumption when cycling at a constant work rate. 4 indexed citations
11.
Carmichael, James, J. L. Loomis, & J. L. Hodgson. (1982). THE EFFECT OF CRANKLENGTH ON OXYGEN CONSUMPTION AND HEART RATE WHEN CYCLING AT A CONSTANT POWER OUTPUT. Medicine & Science in Sports & Exercise. 14(2). 162–162. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026